Dark
Light
System
Institutional Investment Manager
RA CAPITAL MANAGEMENT, L.P.
RA CAPITAL MANAGEMENT, L.P. (CIK: 0001346824) incorporated in Delaware, located at 200 Berkeley Street, 18th Floor, Boston, MA. Institutional holdings reported to the SEC.

Institutional Holdings (2017Q2)
Portfolio Summary: 22 holdings with a total value of $871,430,000.
#
Name
Shares
Value ($)
%
Options
Notes
1 PROTEON THERAPEUTICS INC 1,337,462 2,040,000 0.23%
2 KALVISTA PHARMACEUTICALS INC 591,070 4,350,000 0.50%
3 TG THERAPEUTICS INC 700,000 7,035,000 0.81%
4 Dicerna Pharmaceuticals 2,428,571 7,699,000 0.88%
5 SANGAMO THERAPEUTICS INCORPORATED 1,250,000 11,000,000 1.26%
6 AKEBIA THERAPEUTICS INC COM 836,337 12,018,000 1.38%
7 ACORDA THERAPEUTICS INC 900,259 17,735,000 2.04%
8 AVEO PHARMACEUTICALS INC 8,435,584 18,727,000 2.15%
9 AQUINOX PHARMACEUTICALS INC 1,396,071 19,643,000 2.25%
10 ZOGENIX INC 1,474,688 21,383,000 2.45%
11 RADIUS HEALTH INC 497,157 22,486,000 2.58%
12 RA PHARMACEUTICALS INC COM 1,351,808 25,333,000 2.91%
13 BIOCRYST PHARMACEUTICALS 5,162,242 28,702,000 3.29%
14 MYOVANT SCIENCES LTD 2,807,550 32,848,000 3.77%
15 Esperion Therapeutics Inc 731,531 33,855,000 3.88%
16 IGNYTA INC COM 4,016,990 41,576,000 4.77%
17 G1 THERAPEUTICS INC 2,684,244 46,813,000 5.37%
18 BIOHAVEN PHARMACTL HLDG CO L COM ADDED 2,448,350 61,209,000 7.02%
19 ACHILLION PHARMACEUTICALS IN 13,633,220 62,576,000 7.18%
20 AVEXIS INC COM 1,310,046 107,633,000 12.35%
21 WAVE LIFE SCIENCES LTD 7,088,651 131,849,000 15.13%
22 Ascendis Pharma 5,580,690 154,920,000 17.78%

Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0001144204-17-043212, filed 2017.08.14).

From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.